PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 29 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $88,804 | +142.0% | 17,585 | +141.1% | 0.00% | – |
Q2 2023 | $36,694 | -89.5% | 7,295 | -72.6% | 0.00% | -100.0% |
Q4 2022 | $351,014 | +35001.4% | 26,592 | +1329500.0% | 0.00% | – |
Q1 2020 | $1,000 | -80.0% | 2 | 0.0% | 0.00% | – |
Q4 2019 | $5,000 | -90.7% | 2 | -87.5% | 0.00% | – |
Q3 2019 | $54,000 | -43.8% | 16 | 0.0% | 0.00% | – |
Q2 2019 | $96,000 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 117,242 | $396,000 | 0.12% |
Sofinnova Investments, Inc. | 142,635 | $482,000 | 0.04% |
INSPIRION WEALTH ADVISORS, LLC | 22,075 | $75,000 | 0.03% |
Iron Gate Global Advisors LLC | 14,641 | $49,000 | 0.03% |
REGENTATLANTIC CAPITAL LLC | 18,245 | $62,000 | 0.00% |
Ellis Investment Partners, LLC | 3,250 | $10,000 | 0.00% |
ADVANTAGE INVESTMENT MANAGEMENT, LLC | 45 | $0 | 0.00% |
Renaissance Technologies | 91,569 | $309,000 | 0.00% |
BARCLAYS PLC | 1 | $0 | 0.00% |
D. E. Shaw & Co., Inc. | 13,678 | $46,000 | 0.00% |